Leprosy Mailing List – December 3, 2015
Ref.: (LML) Draft WHO Leprosy Strategy 2016-2020
From: Jaison Barreto, Bauru, Brazil
Dear Pieter,
Related to change in MDT schemes (LML, December 1, 2015), some aspects must be remembered:
- Minocycline or quinolones are not safe for pregnant women or children under 5 years old. This fact avoids their administration without follow up from physicians.
- The pigmentation induced by clofazimine depends on the patient’s infiltration, and it is self-limited.
- Minocycline also can induce hyperpigmentation, sometimes more intense than clofazimine, and it is important to say that photosensitivity or even lupus erythematosus can develop after its administration.
Regards,
Jaison
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
 | This email has been sent from a virus-free computer protected by Avast. www.avast.com |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.